2.11 USD
-0.03 (-1.4%)
SLSN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 81 industry peers in the Chemicals industry. While SLSN is still in line with the averages on profitability rating, there are concerns on its financial health. SLSN is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SLSN was profitable.
SLSN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: SLSN reported negative net income in multiple years.
In multiple years SLSN reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 8.73%, SLSN belongs to the best of the industry, outperforming 91.36% of the companies in the same industry.
SLSN has a Return On Equity of 28.78%. This is amongst the best in the industry. SLSN outperforms 96.30% of its industry peers.
With a decent Return On Invested Capital value of 9.33%, SLSN is doing good in the industry, outperforming 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.73% | ||
| ROE | 28.78% | ||
| ROIC | 9.33% |
ROA(3y)-4.23%
ROA(5y)0.56%
ROE(3y)-82.95%
ROE(5y)-36.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SLSN's Profit Margin of 8.13% is fine compared to the rest of the industry. SLSN outperforms 77.78% of its industry peers.
SLSN's Profit Margin has been stable in the last couple of years.
SLSN has a Operating Margin (7.98%) which is in line with its industry peers.
In the last couple of years the Operating Margin of SLSN has grown nicely.
SLSN's Gross Margin of 28.14% is in line compared to the rest of the industry. SLSN outperforms 53.09% of its industry peers.
In the last couple of years the Gross Margin of SLSN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.98% | ||
| PM (TTM) | 8.13% | ||
| GM | 28.14% |
OM growth 3Y4.13%
OM growth 5YN/A
PM growth 3Y0.93%
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y8.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SLSN is creating some value.
The number of shares outstanding for SLSN has been increased compared to 1 year ago.
The number of shares outstanding for SLSN has been increased compared to 5 years ago.
SLSN has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.57, we must say that SLSN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.57, SLSN is in line with its industry, outperforming 40.74% of the companies in the same industry.
SLSN has a Debt/Equity ratio of 0.91. This is a neutral value indicating SLSN is somewhat dependend on debt financing.
SLSN has a worse Debt to Equity ratio (0.91) than 61.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.57 |
ROIC/WACC1.09
WACC8.58%
2.3 Liquidity
A Current Ratio of 1.72 indicates that SLSN should not have too much problems paying its short term obligations.
SLSN has a worse Current ratio (1.72) than 62.96% of its industry peers.
SLSN has a Quick Ratio of 1.72. This is a bad value and indicates that SLSN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.84, SLSN is not doing good in the industry: 80.25% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
SLSN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.00%.
SLSN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.20% yearly.
The Revenue has grown by 40.35% in the past year. This is a very strong growth!
Measured over the past years, SLSN shows a very strong growth in Revenue. The Revenue has been growing by 33.15% on average per year.
EPS 1Y (TTM)-50%
EPS 3Y9.2%
EPS 5YN/A
EPS Q2Q%-150%
Revenue 1Y (TTM)40.35%
Revenue growth 3Y21.09%
Revenue growth 5Y33.15%
Sales Q2Q%-13.46%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
SLSN is valuated quite expensively with a Price/Earnings ratio of 211.00.
Based on the Price/Earnings ratio, SLSN is valued a bit more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.65, SLSN is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 211 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SLSN is valued expensively inside the industry as 82.72% of the companies are valued cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 27.72 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
SLSN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:SLSN (11/25/2025, 10:31:27 AM)
2.11
-0.03 (-1.4%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners6.24%
Inst Owner ChangeN/A
Ins Owners26.64%
Ins Owner Change0%
Market Cap148.71M
Revenue(TTM)52.35M
Net Income(TTM)5.23M
AnalystsN/A
Price TargetN/A
Short Float %3.93%
Short Ratio17.68
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 211 | ||
| Fwd PE | N/A | ||
| P/S | 2.31 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 8.18 | ||
| P/tB | 8.18 | ||
| EV/EBITDA | 27.72 |
EPS(TTM)0.01
EY0.47%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.91
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.73% | ||
| ROE | 28.78% | ||
| ROCE | 13.74% | ||
| ROIC | 9.33% | ||
| ROICexc | 10.31% | ||
| ROICexgc | 10.31% | ||
| OM | 7.98% | ||
| PM (TTM) | 8.13% | ||
| GM | 28.14% | ||
| FCFM | N/A |
ROA(3y)-4.23%
ROA(5y)0.56%
ROE(3y)-82.95%
ROE(5y)-36.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y17.57%
ROICexgc growth 5YN/A
ROICexc growth 3Y17.57%
ROICexc growth 5YN/A
OM growth 3Y4.13%
OM growth 5YN/A
PM growth 3Y0.93%
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y8.11%
F-Score4
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.74 | ||
| Cap/Depr | 579.23% | ||
| Cap/Sales | 8.18% | ||
| Interest Coverage | 7.91 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.57 |
F-Score4
WACC8.58%
ROIC/WACC1.09
Cap/Depr(3y)375.85%
Cap/Depr(5y)357.51%
Cap/Sales(3y)6.36%
Cap/Sales(5y)6.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3Y9.2%
EPS 5YN/A
EPS Q2Q%-150%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.35%
Revenue growth 3Y21.09%
Revenue growth 5Y33.15%
Sales Q2Q%-13.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y634.96%
EBIT growth 3Y26.09%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-147.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-545.22%
OCF growth 3Y-5.29%
OCF growth 5YN/A
SOLESENCE INC / SLSN FAQ
What is the ChartMill fundamental rating of SOLESENCE INC (SLSN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SLSN.
What is the valuation status of SOLESENCE INC (SLSN) stock?
ChartMill assigns a valuation rating of 0 / 10 to SOLESENCE INC (SLSN). This can be considered as Overvalued.
What is the profitability of SLSN stock?
SOLESENCE INC (SLSN) has a profitability rating of 5 / 10.